Corporate finance business Marechale Capital (LON: MAC) has obtained FCA approval for the acquisition of Stanford Capital Partners. This is one of the three acquisitions announced the previous week that will scale up the business. The share price increased a further 56.2% to 6.95p and it is 248% higher over two weeks.
Medpal AI (LON: MPAL) says that the UK regulatory approval of the first oral GLP-1 receptor agonist tablet developed by Novo Nordisk has come earlier than expected and this will provide a boost for the company’s New Health weight management clinic. It broadens the potential market. The share price gained 50.9% to 4.15p.
Mindflair (LON: MFAI) says CameraMatics, an investee company of Sure Valley Ventures, is raising up to €49m and Sure Valley Ventures first fund is realising part of its investment. This means that Mindflair, which invests in the fund, will receive a share of €280,000 in cash and will have a €320,000 working capital facility repaid. It also owns 24.4% of Sure Ventures plc which will receive €880,000. The share price rose 29.4% to 0.55p.
Altitude Group (LON: ALT) director Martin Varley bought 180,222 shares at 19p each and 26,124 shares at 21.8p each. He owns 13.8% of the promotional products services provider. The share price improved 23.7% to 23.5p.
FALLERS
Marketing services provider Silver Bullet Data Services (LON: SBDS) is asking for shareholder approval for a departure from AIM. It argues that the weak financial markets mean that the company is undervalued and hampers its ability to raise money. This will also save £500,000 each year. A general meeting will be held on 25 June. A matched bargains facility operated by JP Jenkins will operate for at least 12 months. The company joined AIM on 28 June when it was valued at £34.5m at the placing price of 257p. The share price slumped 67.9% to 8.5p.
Shares in Pri0R1Ty Intelligence (LON: PR1) slid 48.5% to 0.875p when they returned from suspension. The AI software business generated revenues of £174,000 in the year to September 2025 and the underlying loss was £3.3m. Cash was £796,000 at the end of September 2025. So far this year contracted revenues are more than £400,000. Prior to the results announcement the company announced an unsecured convertible loan note of £1.25m, and an At-The-Market facility will enable repayment of the convertible through share issues. The cash will provide working capital.
Ascent Resources (LON: AST) admitted that its 2025 results would not be published before the end of June. This is due to the consolidation of US acquisitions. Trading in the shares will be suspended on 1 July. Funding options are being assessed. The share price declined 30% to 0.35p.
Atome Energy (LON: ATOM) says that a presidential decree relating to the fixed price power purchase agreement with ANDE in Paraguay has been revoked. This means that there is uncertainty about the electricity tariffs for the Viletta fertiliser production project. The share price fell 29.1% to 39p.